首页> 外国专利> METHOD FOR REDUCTION AND PREVENTION OF CARDIOVASCULAR BY-EFFECTS INDUCED BY APPLICATION OF PHOSPHODIESTERASE TYPE 5 INHIBITORS FOR TREATMENT OF ERECTILE DYSFUNCTION IN MEN

METHOD FOR REDUCTION AND PREVENTION OF CARDIOVASCULAR BY-EFFECTS INDUCED BY APPLICATION OF PHOSPHODIESTERASE TYPE 5 INHIBITORS FOR TREATMENT OF ERECTILE DYSFUNCTION IN MEN

机译:减少和预防磷酸二酯酶5型抑制剂治疗男性勃起功能障碍引起的心血管副反应的方法

摘要

FIELD: medicine; sexual pathology.;SUBSTANCE: prevention of cardiovascular by-effects induced by introduction of phosphodiesterase type 5 inhibitors for treatment of erectile dysfunction in men is ensured with introduction of one preparation from the specified group: Sildenafil citrate dosed 25-100 mg, or Vardenafil hydrochloride dosed 5-20 mg, or Tadalafil dosed 20 mg, combined with introduction of De-Nol dosed 1 tablet.;EFFECT: improved microcirculation due to higher synthesis of endogenous prostaglandins and prevented cardiovascular by-effects induced by introduction of specified preparations, improved erection in present category of patients.;1 ex
机译:领域:医学;性病理学;物质:通过引入指定组中的一种制剂,可确保预防因引入5型磷酸二酯酶抑制剂治疗男性勃起功能障碍而引起的心血管副反应:柠檬酸西地那非25-100 mg,或盐酸伐地那非剂量5-20毫克或他达拉非20毫克,并加入De-Nol 1片;效果:由于内源性前列腺素的合成增加而改善了微循环,并防止了由于引入特定制剂而引起的心血管副作用,改善了勃起在目前的患者类别中; 1前

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号